Image (528da2a7 3d39 42f1 B4b2 17994a7fbb5d 01)
Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 70771-1527
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 70771-1527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (528da2a7 3d39 42f1 B4b2 17994a7fbb5d 02)
This text provides results from a clinical trial comparing the efficacy of Propafenone ER to a placebo. The data shows the number of events at various time points for both Propafenone ER and placebo groups. The study also tested the effects of different dosages of Propafenone ER. Patient closeout began on day 273 and lasted until day 300. One of the patients on 325 mg experienced an event on day 291, resulting in a significant decline in the Kaplan-Meier curves.*
Label (528da2a7 3d39 42f1 B4b2 17994a7fbb5d 03)
This is a description of a medication called "Propafenone propalenne hydrociorids, USP". It comes in the form of extended-release capsules with each capsule containing 225 mg of the medication. Usual dosage information can be found in the package insert. The manufacturer is Zydus and it should be kept out of reach of children. The rest of the text is unclear or not relevant.*
Label (528da2a7 3d39 42f1 B4b2 17994a7fbb5d 04)
This is a description of a drug named "Propafenone Hydrochloride" which comes in the form of extended-release capsules. The package contains 60 capsules, each of which contains 325mg of Propafenone Hydrochloride, USP. The package insert should be referred to for complete prescribing information. The drug must be stored at 20° to 25°C (66° to 77°F) and dispensed in a tight container. The package is child-resistant and manufactured by Cadla Healthcare Ltd., India.*
Label (528da2a7 3d39 42f1 B4b2 17994a7fbb5d 05)
This text seems to be a medication label with instructions and warnings for usage. The medication is in the form of extended-release capsules in two different variants called Propafenone Hydrochloride and Snmmiiomn with specific sizes. The label contains instructions to dispense the medication in a defined container and warns to keep the product out of children's reach. The medication seems to be available only on prescription through Cadia Healthcare L, Kings.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
